Leclercq I. Non-alcoholic fatty liver disease[J]. Bull Mem Acad R Med Belg, 2010, 165(3-4): 147-155.
[2]
Esteghamati A, Noshad S, Khalilzadeh O, et al. Insulin resistance is independently associated with liver aminotransferases in diabetic patients without ultrasound signs of nonalcoholic Fatty liver disease[J]. Metab Syndr Relat Disord, 2011, 9(2): 111-117.
[3]
Smith AJ, Sanders MA, Thompson BR, et al. Physical association between the adipocyte fatty acid-binding protein and hormone-sensitive lipase: a fluorescence resonance energy transfer analysis[J]. J Biol Chem. 2004, 279(50): 52399-52405.
[4]
Jin J, Peng DQ, Yuan SG, et al. Serum adipocyte fatty acid binding proteins and adiponectin in patients with coronary artery disease: the significance of A-FABP/adiponectin ratio[J]. Clin Chim Acta, 2010, 411(21-22): 1761-1765.
Arrese M. Nonalcoholic fatty liver disease. liver disease: an overlooked complication of diabetes mellitus[J]. Nat Rev Endocrinol, 2010, 6(12): 660-661.
[8]
Ferreira DM, Castro RE, Machado MV, et al. Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease[J]. Diabetologia, 2011, 54(7): 1788-1798.
[9]
Chen SH, He F, Zhou HL, et al. Relationship between nonalcoholic fatty liver disease and metabolic syndrome[J]. J Dig Dis, 2011, 12(2): 125-130.
[10]
García-Monzón C, Lo Iacono O, Mayoral R, et al. Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C[J]. J Hepatol, 2011, 54(1): 142-152.
[11]
Xu A, Wang Y, Xu JY, et al. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome[J]. Clin Chem, 2006, 52(3): 405-413.
[12]
Tso AW, Xu A, Sham PC, et al. Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort[J]. Diabetes Care, 2007, 30(10): 2667-2672.